1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Session

$Thumbnail for Real-World Comparative Survival and Hospitalization Outcomes After CAR-T Relapse in Relapsed/Refractory Multiple Myeloma: Bispecific Antibodies Versus Conventional Chemotherapy$

MM - 1417

Real-World Comparative Survival and Hospitalization Outcomes After CAR-T Relapse in Relapsed/Refractory Multiple Myeloma: Bispecific Antibodies Versus Conventional Chemotherapy

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for Infectious Complications in Hospitalized Multiple Myeloma Patients: Type-Specific Mortality, Burden, and Resource Utilization from the 2022 National Inpatient Sample

MM - 1428

Infectious Complications in Hospitalized Multiple Myeloma Patients: Type-Specific Mortality, Burden, and Resource Utilization from the 2022 National Inpatient Sample

Kriti Yadav

Poster Presenter: Kriti Yadav

SOHO 2026 Annual Meeting

Posters by Session

Real-World Comparative Survival and Hospitalization Outcomes After CAR-T Relapse in Relapsed/Refractory Multiple Myeloma: Bispecific Antibodies Versus Conventional Chemotherapy

Infectious Complications in Hospitalized Multiple Myeloma Patients: Type-Specific Mortality, Burden, and Resource Utilization from the 2022 National Inpatient Sample

Risk of Secondary Acute Myeloid Leukemia Following CAR-T Therapy in Multiple Myeloma

Rising Mortality from Multiple Myeloma-Associated Heart Failure in Older US Adults: A CDC WONDER Analysis (1999-2024)

Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

Second Primary Malignancies in Multiple Myeloma: A Retrospective Population-Based Analysis

Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma

Daratumumab-Based Treatment Strategies with Daratumumab-Lenalidomide Maintenance vs Lenalidomide Maintenance in Transplant Eligible NDMM: A Systematic Review and Meta-Analysis

Comparative Evaluation of Large Language Models (LLMs) for Guideline-Concordant Therapy Selection in Multiple Myeloma: A Cross-Sectional Assessment of ChatGPT, Claude, and Gemini